ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATYR ATYR PHARMA INC

休市中 12-12 16:00:00 EST

0.7755

+0.0102

+1.33%

盘后0.7611

-0.0144-1.86%

19:59 EST

最高0.7950	最低0.7579	成交量155.85万
今开0.7579	昨收0.7653	日振幅4.85%
总市值7,599万	流通市值7,442万	总股本9,799万
成交额120.86万	换手率1.62%	流通股本9,597万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATYR","market":"US","secType":"STK","nameCN":"ATYR PHARMA INC","latestPrice":0.7755,"timestamp":1765573200000,"preClose":0.7653,"halted":0,"volume":1558483,"hourTrading":{"tag":"盘后","latestPrice":0.7611,"preClose":0.7755,"latestTime":"19:59 EST","volume":36798,"amount":28144.991,"timestamp":1765587583739},"delay":0,"floatShares":95966000,"shares":97986634,"eps":-0.842499,"marketStatus":"休市中","change":0.0102,"latestTime":"12-12 16:00:00 EST","open":0.7579,"high":0.795,"low":0.7579,"amount":1208572.0851434001,"amplitude":0.048478,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.842499,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1430971200000,"exchange":"NASDAQ","adjPreClose":0.7653,"preHourTrading":{"tag":"盘前","latestPrice":0.762,"preClose":0.7653,"latestTime":"09:24 EST","volume":20979,"amount":16003.7105697,"timestamp":1765549499861},"postHourTrading":{"tag":"盘后","latestPrice":0.7611,"preClose":0.7755,"latestTime":"19:59 EST","volume":36798,"amount":28144.991,"timestamp":1765587583739},"volumeRatio":0.9429781516655539,"optionData":{"bulkOrders":[{"symbol":"ATYR","call":false,"expireDate":1778817600000,"strike":"2.0","timestamp":1765569253266,"price":1.29,"volume":1200,"amount":154800,"type":"+"},{"symbol":"ATYR","call":false,"expireDate":1766120400000,"strike":"2.0","timestamp":1765569253266,"price":1.26,"volume":1200,"amount":151200,"type":"-"}]},"impliedVol":2.3629,"impliedVolPercentile":0.768},"requestUrl":"/m/hq/s/ATYR","defaultTab":"news","newsList":[{"id":"2586418212","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.00%报0.698美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586418212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586418212?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:33","pubTimestamp":1763994800,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时33分，Atyr Pharma, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报0.698美元/股，成交量5.4894万股，换手率0.06%，振幅4.50%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223321977cabaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223321977cabaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTTA","ATYR"],"gpt_icon":0},{"id":"2585317922","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.16%报0.685美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585317922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585317922?lang=zh_cn&edition=full","pubTime":"2025-11-22 01:54","pubTimestamp":1763747667,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日01时54分，Atyr Pharma, Inc.股票出现异动，股价大幅上涨5.16%。截至发稿，该股报0.685美元/股，成交量119.212万股，换手率1.22%，振幅6.75%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015428a7098337&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015428a7098337&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2579210685","title":"Atyr Pharma, Inc.盘中异动 下午盘股价大跌5.02%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579210685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579210685?lang=zh_cn&edition=full","pubTime":"2025-10-31 02:14","pubTimestamp":1761848097,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日02时14分，Atyr Pharma, Inc.股票出现异动，股价大幅跳水5.02%。截至发稿，该股报0.920美元/股，成交量238.338万股，换手率2.43%，振幅4.15%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103102145894e5f739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103102145894e5f739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2569974629","title":"Atyr Pharma, Inc.盘中异动 临近收盘快速下跌6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569974629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569974629?lang=zh_cn&edition=full","pubTime":"2025-09-24 03:56","pubTimestamp":1758657380,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日03时56分，Atyr Pharma, Inc.股票出现异动，股价急速下挫6.05%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.30%。其相关个股中，木薯科学、Surrozen Inc C/Wts 01/08/2031 、Galecto, Inc.涨幅较大，Galecto, Inc.、Silo Pharma, Inc.、Soligenix, Inc.较为活跃，换手率分别为4050.45%、360.01%、184.71%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、木薯科学、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为68.73%、48.49%、48.46%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924035620a6999ee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924035620a6999ee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"1137305404","title":"异动解读 | ATYR制药公司股价夜盘大涨23.15%后暴跌81.8%，肺病新药试验失败","url":"https://stock-news.laohu8.com/highlight/detail?id=1137305404","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137305404?lang=zh_cn&edition=full","pubTime":"2025-09-16 08:02","pubTimestamp":1757980947,"startTime":"0","endTime":"0","summary":"ATYR制药公司股价在夜盘交易中大涨23.15%后，周一盘中遭遇重创，暴跌81.8%至1.09美元的历史新低。这种剧烈的价格波动源于该公司最新公布的临床试验结果。ATYR制药公司周一宣布，其用于治疗肺肉瘤病的新药efzofitimod在一项后期临床研究中未能达到主要终点。该试验旨在证明，与安慰剂相比，使用efzofitimod的患者在48周后每日类固醇用量的削减幅度更大。这一令人失望的结果对ATYR制药公司的前景造成了严重打击。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ATYR"],"gpt_icon":1},{"id":"1122596588","title":"aTyr Pharma Inc：Leerink Partners将评级从跑赢大盘下调至与大盘持平，目标价从16美元下调至1美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122596588","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122596588?lang=zh_cn&edition=full","pubTime":"2025-09-15 23:33","pubTimestamp":1757950396,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc：Leerink Partners将评级从跑赢大盘下调至与大盘持平，目标价从16美元下调至1美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"1125274879","title":"异动解读 | aTyr Pharma股价盘前暴跌79.77%，肺病新药后期试验未达主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1125274879","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125274879?lang=zh_cn&edition=full","pubTime":"2025-09-15 20:30","pubTimestamp":1757939424,"startTime":"0","endTime":"0","summary":"周一盘前交易中，生物制药公司aTyr Pharma股价大幅下跌79.77%，投资者对公司核心产品研发失利反应强烈。根据公司最新公告，aTyr Pharma的实验性药物efzofitimod在针对肺肉瘤病患者的后期临床试验中未能达到主要目标。尽管试验结果不尽如人意，但aTyr Pharma表示，efzofitimod的安全性与先前的研究结果一致。目前，已获批准的肺肉瘤病一线治疗方法主要是皮质类固醇激素，如泼尼松。aTyr Pharma此次研发失利，无疑打击了市场对公司开发新型治疗方案的期待，从而导致股价大幅下挫。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ATYR"],"gpt_icon":0},{"id":"1193378701","title":"aTyr Pharma宣布Efzofitimod治疗肺结节病的第3期Efzo-Fit™研究顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1193378701","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193378701?lang=zh_cn&edition=full","pubTime":"2025-09-15 19:30","pubTimestamp":1757935859,"startTime":"0","endTime":"0","summary":"aTyr Pharma宣布Efzofitimod治疗肺结节病的第3期Efzo-Fit™研究顶线结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2566997849","title":"Atyr Pharma, Inc.盘中异动 大幅拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566997849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566997849?lang=zh_cn&edition=full","pubTime":"2025-09-11 23:19","pubTimestamp":1757603947,"startTime":"0","endTime":"0","summary":"北京时间2025年09月11日23时19分，Atyr Pharma, Inc.股票出现波动，股价急速上涨5.15%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Maze Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Silexion Therapeutics Corp、Gri Bio, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为2251.40%、2183.07%、199.90%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp、Gri Bio, Inc.，振幅分别为155.42%、72.91%、58.33%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911231907a71c4cd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911231907a71c4cd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"1194283090","title":"aTyr Pharma宣布根据纳斯达克上市规则5635(C)(4)授予激励股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1194283090","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194283090?lang=zh_cn&edition=full","pubTime":"2025-09-06 05:58","pubTimestamp":1757109529,"startTime":"0","endTime":"0","summary":"9月5日 - aTyr Pharma Inc宣布根据纳斯达克上市规则5635(C)(4)授予激励股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2565472587","title":"Atyr Pharma, Inc.盘中异动 早盘急速下挫5.08%报5.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565472587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565472587?lang=zh_cn&edition=full","pubTime":"2025-09-04 22:47","pubTimestamp":1756997262,"startTime":"0","endTime":"0","summary":"北京时间2025年09月04日22时47分，Atyr Pharma, Inc.股票出现波动，股价快速下挫5.08%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Novabay Pharmaceuticals, Inc.、冠科美博涨幅较大，Purple Biotech Ltd、Soligenix, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1559.37%、133.99%、61.27%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、冠科美博、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为36.08%、35.56%、25.68%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904224742a70fe120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904224742a70fe120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"1133718952","title":"异动解读 | ATYR PHARMA盘中大涨8.11%，业绩低于预期但长期前景乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1133718952","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133718952?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:06","pubTimestamp":1754921206,"startTime":"0","endTime":"0","summary":"生物制药公司ATYR PHARMA今日盘中大涨8.11%，尽管公司最新公布的季度业绩未达分析师预期。这一涨幅引起了投资者的广泛关注。值得注意的是，ATYR PHARMA的股价在本季度已上涨4.5%，今年迄今为止更是累计上涨了46.4%，显示出强劲的市场表现。分析师对ATYR PHARMA保持看好态度，目前对该公司股票的平均评级为\"买入\"。ATYR PHARMA作为一家专注于tRNA合成酶平台的生物治疗公司，其主要产品efzofitimod在治疗肺部炎症和纤维化方面显示出潜力，这可能是投资者保持乐观的另一个原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ATYR"],"gpt_icon":1},{"id":"2558665507","title":"Atyr Pharma, Inc.盘中异动 急速拉升5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558665507","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558665507?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:37","pubTimestamp":1754919424,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时37分，Atyr Pharma, Inc.股票出现异动，股价大幅上涨5.47%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Entero Therapeutics Inc.、Artelo Biosciences, Inc.、Indaptus Therapeutics, Inc.涨幅较大，Entero Therapeutics Inc.、Io Biotech, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2082.58%、79.21%、30.46%，振幅较大的相关个股有Entero Therapeutics Inc.、Io Biotech, Inc.、Nucana Plc，振幅分别为38.56%、14.06%、13.66%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213704a6dfba9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213704a6dfba9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"1123968363","title":"异动解读 | ATYR PHARMA股价盘前大涨7.17%，尽管季度业绩未达预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1123968363","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123968363?lang=zh_cn&edition=full","pubTime":"2025-08-11 20:04","pubTimestamp":1754913866,"startTime":"0","endTime":"0","summary":"生物制药公司ATYR PHARMA INC今日盘前股价大涨7.17%，尽管公司最新公布的季度业绩未达分析师预期。这一涨幅引起了投资者的广泛关注。值得注意的是，ATYR PHARMA的股价在本季度已上涨4.5%，今年迄今为止更是累计上涨了46.4%，显示出强劲的市场表现。分析师对ATYR PHARMA保持看好态度，目前对该公司股票的平均评级为\"买入\"。这一乐观预期可能是推动股价上涨的主要原因之一。尽管公司本季度业绩略低于预期，但投资者似乎更加关注其长期增长潜力和行业前景。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ATYR"],"gpt_icon":0},{"id":"2557561341","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.24%报5.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557561341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557561341?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:34","pubTimestamp":1754573667,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时34分，Atyr Pharma, Inc.股票出现波动，股价急速拉升5.24%。截至发稿，该股报5.62美元/股，成交量21.4593万股，换手率0.24%，振幅3.52%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508072134279739b279&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508072134279739b279&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2556870503","title":"Atyr Pharma, Inc.盘中异动 早盘快速上涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556870503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556870503?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:30","pubTimestamp":1754314253,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时30分，Atyr Pharma, Inc.股票出现异动，股价大幅拉升5.32%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2104.00%、742.85%、368.85%，振幅较大的相关个股有凯信远达、Camp4 Therapeutics Corporation、Psyence Biomedical Ltd.，振幅分别为11.47%、9.08%、8.46%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042130549732ef9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042130549732ef9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2556344848","title":"Atyr Pharma, Inc.盘中异动 大幅下跌5.25%报4.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556344848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556344848?lang=zh_cn&edition=full","pubTime":"2025-08-02 01:02","pubTimestamp":1754067748,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日01时02分，Atyr Pharma, Inc.股票出现波动，股价急速跳水5.25%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Revolution Medicines Inc C/Wts 17/12/2026 、Equillium, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为1699.87%、242.02%、194.91%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、天境生物、Bioxcel Therapeutics, Inc.，振幅分别为72.18%、58.71%、55.95%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080201022994c95ecb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080201022994c95ecb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2555856029","title":"Atyr Pharma, Inc.盘中异动 股价大跌5.05%报4.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555856029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555856029?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:38","pubTimestamp":1753900725,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时38分，Atyr Pharma, Inc.股票出现异动，股价大幅下跌5.05%。截至发稿，该股报4.98美元/股，成交量472.6万股，换手率5.31%，振幅5.34%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073102384594c46ae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073102384594c46ae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2555359052","title":"Atyr Pharma, Inc.盘中异动 快速下跌5.03%报5.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555359052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555359052?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:31","pubTimestamp":1753795914,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时31分，Atyr Pharma, Inc.股票出现波动，股价大幅跳水5.03%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Salarius Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.、Scinai Immunotherapeutics Ltd涨幅较大，Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为2434.46%、1612.41%、1109.37%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.、Tnf Pharmaceuticals, Inc.，振幅分别为39.12%、18.20%、15.92%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213154a469c794&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213154a469c794&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2554721347","title":"Atyr Pharma, Inc.盘中异动 早盘急速上涨5.32%报6.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554721347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554721347?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:30","pubTimestamp":1753709432,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时30分，Atyr Pharma, Inc.股票出现异动，股价急速上涨5.32%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Cervomed Inc.涨幅较大，Aim Immunotech Inc.、Cervomed Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为212.49%、79.70%、79.66%，振幅较大的相关个股有Celcuity Inc.、Aim Immunotech Inc.、Mersana Therapeutics, Inc.，振幅分别为23.86%、15.47%、8.31%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821303294bf6e28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821303294bf6e28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atyrpharma.com","stockEarnings":[{"period":"1week","weight":-0.0587},{"period":"1month","weight":0.0729},{"period":"3month","weight":-0.8714},{"period":"6month","weight":-0.8509},{"period":"1year","weight":-0.7432},{"period":"ytd","weight":-0.7858}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"aTyr Pharma, Inc.于2005年9月8日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，利用进化智能将tRNA合成酶生物学转化为纤维化和炎症的新疗法。tRNA合成酶是古老的、必需的蛋白质，它们已经进化出新的结构域，在人类的胞外调节不同的途径。该公司的发现平台专注于通过发现由所有20种tRNA合成酶衍生的结构域专有库驱动的信号通路来解锁隐藏的治疗干预点。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.026814},{"month":2,"riseRate":0.4,"avgChangeRate":-0.021771},{"month":3,"riseRate":0.4,"avgChangeRate":-0.056841},{"month":4,"riseRate":0.3,"avgChangeRate":-0.032312},{"month":5,"riseRate":0.5,"avgChangeRate":-0.058101},{"month":6,"riseRate":0.545455,"avgChangeRate":-0.018872},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.001577},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.059775},{"month":9,"riseRate":0.454545,"avgChangeRate":0.014241},{"month":10,"riseRate":0.363636,"avgChangeRate":0.029504},{"month":11,"riseRate":0.545455,"avgChangeRate":0.024303},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.06206}],"exchange":"NASDAQ","name":"ATYR PHARMA INC","nameEN":"ATYR PHARMA INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ATYR PHARMA INC(ATYR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ATYR PHARMA INC,ATYR,ATYR PHARMA INC股票,ATYR PHARMA INC股票老虎,ATYR PHARMA INC股票老虎国际,ATYR PHARMA INC行情,ATYR PHARMA INC股票行情,ATYR PHARMA INC股价,ATYR PHARMA INC股市,ATYR PHARMA INC股票价格,ATYR PHARMA INC股票交易,ATYR PHARMA INC股票购买,ATYR PHARMA INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ATYR PHARMA INC(ATYR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}